Brain Disorder

3

Review clinical trials related to Brain Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Multicentre, prospective, Multi-arm Multi-stage (MAMS) seamless phase 2b/3 interventional randomized placebo-controlled double-blinded parallel-assignment (2 arms with 1:1 randomization) efficacy and safety trial to test intra-arterial tenecteplase at the completion of thrombectomy versus best practice in participants with anterior circulation LVO receiving mechanical thrombectomy within 24 hours of symptoms onset.

Participants needed: 462
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: University of MelbourneUpdated: May 18, 2026Locations: 12
Eligibility criteria

For 0-6 hours of symptom onset: Presence of arterial occlusion as defined above... [+4]

Intracranial hemorrhage identified by CT or MRI [+13]

Status: Recruiting

Effect of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder

The aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Glove by comparing the effects between a group using the home-based Neofect Smart Glove and a group performing conventional home-based occupational therapy in patients with upper limb dysfunction in the late subacute and chronic stages of neurological diseases.

Participants needed: 40
Trial details
Age: 19-85Biological sex: AllType: InterventionalSponsor: Samsung Medical CenterUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Patients with brain disorder aged 19 to 85 years old [+3]

pre-existing significant neurogenic disorders [+8]

Status: Recruiting

Effect of Untact Upper Extremity Rehabilitation Using a Smart Board for Late Subacute and Chronic Patients With Brain Disorder

The aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Board by comparing the effects between a group using the home-based Neofect Smart Board and a group performing conventional home-based occupational therapy in patients with upper limb dysfunction in the late subacute and chronic stages of neurological diseases.

Participants needed: 40
Trial details
Age: 19-85Biological sex: AllType: InterventionalSponsor: Samsung Medical CenterUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Patients with neurological diseases aged 19 to 85 years old [+4]

pre-existing significant neurogenic disorders [+8]